André, Julia
Zhukouskaya, Volha V. http://orcid.org/0000-0002-2435-1855
Lambert, Anne-Sophie
Salles, Jean-Pierre
Mignot, Brigitte
Bardet, Claire
Chaussain, Catherine
Rothenbuhler, Anya
Linglart, Agnès
Funding for this research was provided by:
Pfizer (53232267)
Article History
Received: 4 June 2022
Accepted: 7 December 2022
First Online: 21 December 2022
Declarations
:
: The study was approved by the French National Data Processing and Liberties Commission (CNIL number 1920371v0), and in accordance with the Jardé law in France, the need for written consent was waived. After patients and/or their parents had been informed orally about the study, oral consent was obtained from parents and oral assent from minors (as appropriate). It was clarified that they had the right to withdraw from the study at any time by completing a form available through ExternalRef removed.
: Not applicable.
: JA nothing to disclose; VVZ reports the speaker’s fees and the travel grants from Kyowa Kirin, Novonordisk, unrelated to this research; ASL nothing to disclose; JPS nothing to disclose; BM nothing to disclose; CB nothing to disclose; CC nothing to disclose; AR reports the speaker’s fees and the travel grants from Kyowa Kirin; AL reports e research grant from Kyowa Kirin, honoraria and consulting fees from Pfizer, Novonordisk, Merck Serono and Sandoz, unrelated to this work.